Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
Guardian Drug Co. Inc.
Presence of foreign substance: small metallic particles in chewable tablets.
CareFusion 213, LLC
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Ajanta Pharma USA Inc
CGMP Deviations
CareFusion 213, LLC
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
CareFusion 213, LLC
Non-Sterility: Due to presence of Aspergillus penicillioides.
CareFusion 213, LLC
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal…
Lannett Company Inc.
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Ajanta Pharma USA Inc
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Glenmark Pharmaceuticals Inc., USA
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
SUN PHARMACEUTICAL INDUSTRIES INC
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
SUN PHARMACEUTICAL INDUSTRIES INC
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Zep Inc
Microbial contamination of sterile products
Keystone Industries
Defective container:may contain bottles with incomplete seals
Keystone Industries
Defective container:may contain bottles with incomplete seals
Keystone Industries
Defective container:may contain bottles with incomplete seals